| scholarly article | Q13442814 |
| P2093 | author name string | Virend K Somers | |
| Andrew D Calvin | |||
| Raouf S Amin | |||
| Diane Davison | |||
| Abu Shamsuzzaman | |||
| P2860 | cites work | Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk | Q28300313 |
| Prospective study of the association between sleep-disordered breathing and hypertension | Q29620492 | ||
| Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses | Q33910496 | ||
| Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Counc | Q34013511 | ||
| Obstructive sleep apnea: implications for cardiac and vascular disease | Q34268299 | ||
| Obstructive sleep apnea as a risk factor for stroke and death | Q34466726 | ||
| Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome | Q35092244 | ||
| Sympathetic neural mechanisms in obstructive sleep apnea. | Q35764596 | ||
| Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities | Q36696149 | ||
| C-reactive protein, fibrinogen, and cardiovascular disease prediction | Q37021409 | ||
| Association of sleep-disordered breathing and the occurrence of stroke | Q37282690 | ||
| Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis | Q38053120 | ||
| Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome | Q39441464 | ||
| Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
| Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation. | Q40726928 | ||
| The role of fibrinogen as a cardiovascular risk factor | Q40819190 | ||
| Fibrinogen: its role in the hemostatic regulation in atherosclerosis | Q40837683 | ||
| Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature | Q40904739 | ||
| Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study | Q41206667 | ||
| Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990 | Q43613193 | ||
| Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. | Q44379232 | ||
| Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study | Q44734148 | ||
| The hypercoagulable state in sleep apnea is related to comorbid hypertension | Q46566404 | ||
| The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study | Q46776418 | ||
| Hypercoagulability in patients with obstructive sleep apnea | Q47411491 | ||
| Morning levels of fibrinogen in children with sleep-disordered breathing | Q47903224 | ||
| Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study | Q48258568 | ||
| Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors | Q48434703 | ||
| Elevated C-reactive protein in patients with obstructive sleep apnea | Q48660954 | ||
| Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight | Q48706749 | ||
| Fibrinogen levels and obstructive sleep apnea in ischemic stroke | Q48708426 | ||
| Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea | Q48709586 | ||
| Circadian interleukin-6 secretion and quantity and depth of sleep | Q48749850 | ||
| Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome | Q48783534 | ||
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. | Q52993523 | ||
| Enhanced synthesis of albumin and fibrinogen at high altitude | Q57112142 | ||
| High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein | Q57113310 | ||
| Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population | Q59608089 | ||
| Fate of fibrinogen in human arterial intima | Q68735946 | ||
| Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 | ||
| Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group | Q71079000 | ||
| Fibrinogen, coronary heart disease and mortality from all causes in smokers and nonsmokers. The study of men born in 1933 | Q71132026 | ||
| Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome | Q71147324 | ||
| Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
| Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity | Q73320092 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obstructive sleep apnea | Q16606552 |
| P304 | page(s) | 761-766 | |
| P577 | publication date | 2014-02-09 | |
| P1433 | published in | Sleep and Breathing | Q15762247 |
| P1476 | title | Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients | |
| P478 | volume | 18 |
| Q49836994 | Alcohol and the risk of sleep apnoea: a systematic review and meta-analysis |
| Q55419378 | Association between obstructive sleep apnea and comorbidities with periodontal disease in adults. |
| Q34697950 | Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives |
| Q38613265 | Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities |
| Q26748713 | Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease |
| Q26747585 | Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats |
| Q35137720 | Inflammation in sleep apnea: an update. |
| Q47803700 | Obstructive sleep apnea might trigger acute pulmonary embolism: results from a cohort study |
| Q89216818 | Obstructive sleep apnoea syndrome |
| Q35645816 | Obstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption |
| Q26799361 | Sleep, death, and the heart |
| Q92388836 | Sleep-Disordered Breathing and Idiopathic Normal-Pressure Hydrocephalus: Recent Pathophysiological Advances |
| Q47855103 | Systemic inflammation in patients with compromised upper airway anatomy and primary snoring or mild obstructive sleep apnea |
| Q30377003 | The Frequency and Energy of Snoring Sounds Are Associated with Common Carotid Artery Intima-Media Thickness in Obstructive Sleep Apnea Patients |
| Q35550460 | The effect of teeth extraction for orthodontic treatment on the upper airway: a systematic review |
Search more.